Back to articles

Pediatrics Group Provides ADHD Treatment and Management Guidelines


In its long-anticipated guidelines on clinical management of attention-deficit/hyperactivity disorder (ADHD), the American Academy of Pediatrics (AAP) formally endorsed use of stimulants as first-line therapy in most affected children aged 6–12 years. Noting that 80% of these patients will respond to stimulants, AAP went as far as recommending reconsideration of the diagnosis in children whose symptoms are unaffected by the medications.


American Academy of Pediatrics: Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033–44.